Loading...

Anti-VEGF Injections

The Gold Standard for Treating Retinal Swelling and Leakage

**Anti-VEGF (Vascular Endothelial Growth Factor) Injections** are the most revolutionary and common treatment for several sight-threatening retinal diseases. They work by blocking a protein called VEGF, which is responsible for stimulating the growth of abnormal, leaky blood vessels and causing fluid buildup in the macula.

We utilize leading Anti-VEGF medications, including **Lucentis**, **Eylea**, and off-label **Avastin**, delivered directly into the vitreous (intravitreal injection) to stop leakage, reduce macular swelling, and prevent further vision loss in conditions like **Wet Age-related Macular Degeneration (AMD)**, **Diabetic Macular Edema (DME)**, and **Retinal Vein Occlusion (RVO)**.

+91 98765 43210

Consult our retina specialist about starting Anti-VEGF therapy.
Anti-VEGF for Wet AMD

Wet AMD Treatment

Stops the growth of abnormal blood vessels that cause rapid central vision loss in Age-related Macular Degeneration.

Anti-VEGF for Diabetic Macular Edema

Diabetic Macular Edema (DME)

Reduces macular swelling and leakage caused by uncontrolled diabetes, preserving reading vision.

Intravitreal injection procedure

Safe, Minimally Invasive Procedure

Performed under strict sterile conditions with topical anesthesia, making the procedure quick and comfortable.

Anti-VEGF for Retinal Vein Occlusion

Retinal Vascular Diseases

Effective treatment for Macular Edema following Retinal Vein Occlusions (RVO).

Frequently Asked Questions About Anti-VEGF Injections

The frequency varies based on the disease and patient response. Initially, injections are often given monthly for 3-6 months. After that, a personalized regimen (like Treat-and-Extend) is used to maintain vision while reducing the frequency as much as possible.

The procedure is generally **painless**. The eye is thoroughly numbed using strong topical anesthetic drops and sometimes a small local anesthetic injection before the treatment, so most patients only feel a sensation of pressure.

The most common side effects are temporary and mild, including a feeling of a scratchy or foreign body sensation, a small red spot (subconjunctival hemorrhage) at the injection site, and temporary floaters. Serious complications are extremely rare.

Some patients report subjective improvement in the first few days. However, objective improvement in vision and reduction of fluid (confirmed by OCT scan) are usually seen after the first **3 monthly injections**. Consistent treatment is key to long-term success.